Conference Coverage

Intense statin therapy treats atheromas in diabetes


 

AT ACC 13

*Correction, 3/27/13: An earlier version of this story incorrectly reported decreased TAV numbers for diabetics and nondiabetics. This version has been updated to reflect the correct numbers.

sboschert@frontlinemedcom.com

On Twitter @sherryboschert

Pages

Recommended Reading

PCSK9 Antibodies Safely Cut LDL in Phase II
MDedge Endocrinology
Statins' Diabetogenic Impact Influenced by Underlying Risks
MDedge Endocrinology
Bariatric surgery cut vascular events in diabetes
MDedge Endocrinology
SSRIs for PTSD bring cardiometabolic benefits
MDedge Endocrinology
HDL-raising: A good hypothesis gone bad
MDedge Endocrinology
Ramipril boosts walking times in PAD with claudication
MDedge Endocrinology
Injectable 'antisense' drug approved for familial hypercholesterolemia
MDedge Endocrinology
CDC: Address high smoking rate among mentally ill
MDedge Endocrinology
Critics dub JNC-8 as 'JNC-Late'
MDedge Endocrinology
TERISA targets diabetes as potential new market for ranolazine
MDedge Endocrinology

Related Articles